Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 9/20 | 0.70 |
| ▸ | RXRB | P28702 | 8/20 | 0.70 |
| ▸ | RXRG | P48443 | 7/20 | 0.70 |
| ▸ | HPGD | P15428 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 3/20 | 0.53 |
| ▸ | RAB9A | P51151 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.53 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.49 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.49 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.49 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | CRHBP | P24387 | 1/20 | 0.48 |
| ▸ | PPARG | P37231 | 1/20 | 0.48 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15125899 | 0.89 | RXRA (0.50) | RXRARXRBRXRGHPGDMAPT | |
| SCHEMBL21798491 | 0.87 | RAB9A (0.72) | RXRARXRBRXRGMAPTRAB9A | |
| SCHEMBL19543235 | 0.87 | RXRA (0.52) | RXRARXRBRXRGHPGDMAPT | |
| SCHEMBL23383976 | 0.86 | RXRA (0.70) | RXRARXRBRXRGHPGDMAPT | |
| SCHEMBL2579088 | 0.86 | MAPT (0.59) | RXRARXRBRXRGMAPTRAB9A | |
| Tucaresol SCHEMBL29400654 | 0.85 | RXRA (0.56) | RXRARXRBRXRGHPGDMAPT | |
| Tucaresol SCHEMBL600942 | 0.85 | RXRA (0.56) | RXRARXRBRXRGHPGDMAPT | |
| SCHEMBL17664765 | 0.84 | MAOB (0.52) | RXRARXRBRXRGHPGDMAPT | |
| SCHEMBL30495975 | 0.84 | RXRA (0.56) | RXRARXRBRXRGHPGDMAPT | |
| SCHEMBL23363642 | 0.84 | RXRA (0.56) | RXRARXRBRXRGHPGDMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4328046-A1 | NITRILE OXIDE COMPOUND AND IONIC-FUNCTIONAL-GROUP-CONTAINING POLYMER | Sumitomo Rubber Industries, Ltd. (JP) | 2024-02-28 | — | — | EP | disclosed |
| WO-2022244317-A1 | NITRILE OXIDE COMPOUND AND IONIC-FUNCTIONAL-GROUP-CONTAINING POLYMER | 住友ゴム工業株式会社 | 2022-11-24 | — | — | WO | disclosed |
| US-10875949-B2 | Polymerizable materials based on dimerizable benzaldehyde derivatives | IVOCLAR VIVADENT AG (LI) | 2020-12-29 | — | — | US | disclosed |
| US-10875949-B2 | Polymerizable materials based on dimerizable benzaldehyde derivatives | IVOCLAR VIVADENT AG (LI) | 2020-12-29 | — | — | US | disclosed |
| EP-3622943-A1 | POLYMERISABLE MATERIALS BASED ON DIMERISATION-CAPABLE BENZALDEHYDE DERIVATIVES | Ivoclar Vivadent AG (LI) | 2020-03-18 | — | — | EP | disclosed |
| US-20200079888-A1 | Polymerizable Materials Based On Dimerizable Benzaldehyde Derivatives | IVOCLAR VIVADENT AG (LI) | 2020-03-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200079888-A1 | Polymerizable Materials Based On Dimerizable Benzaldehyde Derivatives | FANCI, CAD, ALDH1A2 | RXRA 2935/4885RXRB 2812/4885RXRG 3028/4885 |
| US-10875949-B2 | Polymerizable materials based on dimerizable benzaldehyde derivatives | FANCI, CAD, ALDH1A2 | RXRA 2935/4885RXRB 2812/4885RXRG 3028/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.